MBAM
ETON icon

Mink Brook Asset Management’s Eton Pharmaceutcials ETON Stock Holding History

Mink Brook Asset Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,139
Closed -$216K – 48
2025
Q2 		$216K Sell
15,139
-126,349
-89% -$2M 0.19% 33
2025
Q1 		$1.84M Sell
141,488
-314,317
-69% -$4.75M 1.93% 13
2024
Q4 		$6.07M Buy
+455,805
New +$4.62M 5.81% 7

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Mink Brook Asset Management's ETON Position: Q3 2025 in Review

Mink Brook Asset Management sold out of Eton Pharmaceutcials (ETON) in Q3 2025, closing a stake of 15,139 shares — an estimated $216K sold.

Mink Brook Asset Management first reported a position in ETON in Q4 2024 and held it in 3 quarters. The position peaked at $6.07M in Q4 2024. 103 funds tracked by Wall St. Rank hold ETON as of Q3 2025.

  • Mink Brook Asset Management reported no remaining Eton Pharmaceutcials position as of Q3 2025 after selling out during the quarter.
  • Mink Brook Asset Management sold 15,139 Eton Pharmaceutcials shares in Q3 2025, an estimated $216K.
  • Mink Brook Asset Management first reported a position in Eton Pharmaceutcials in Q4 2024 and held it in 3 quarters.
  • Mink Brook Asset Management's Eton Pharmaceutcials position peaked at $6.07M in Q4 2024.
  • 103 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2025.

Based on Mink Brook Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.